eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Cardiothoracic Surgery

Tetralogy of Fallot: Surgical Perspective: Treatment

Author: Vibhuti N Singh, MD, MPH, FACC, FSCAI, Director, Suncoast Cardiovascular Center; Chair, Cardiology Division and Cath Labs, Department of Medicine, Bayfront Medical Center; Clinical Assistant Professor, Division of Cardiology, University of South Florida College of Medicine
Coauthor(s): Jeffrey P Jacobs, MD, FACS, FACC, FCCP, Clinical Associate Professor, Department of Surgery, University of South Florida College of Medicine; Medical Director, ECMO Program, Division of Thoracic and Cardiovascular Surgery, All Children's Hospital/Bayfront Medical Center
Contributor Information and Disclosures

Updated: Nov 13, 2008

Treatment

Medical Therapy

In cyanotic patients with tetralogy of Fallot (TOF), conservative management includes the following:

  • Knee-to-chest positioning
  • Administration of supplemental oxygen
  • Sedation
  • Volume expansion
  • Correction of anemia, if present
  • Additional measures that increase cardiac preload and systemic vascular resistance
  • Beta-blockade to decrease infundibular spasm

In acyanotic patients, medical management is similar to management of a patient with a ventricular septal defect (VSD) and may include diuretics (furosemide [Lasix]), digoxin, and afterload reduction (captopril).

Transcatheter interventions

The role of transcatheter interventions for tetralogy of Fallot is controversial. Most centers do not use transcatheter interventions for tetralogy of Fallot and instead perform surgical palliation and repair, as discussed below.

Some centers advocate balloon dilation of right ventricular (RV) outflow tract (RVOT) infundibular and pulmonary valvar stenosis. The balloon dilation of pulmonary valvar stenosis is more likely to be successful than the dilation of infundibular stenosis. Cutting-balloon angioplasty of pulmonary artery stenosis in tetralogy of Fallot has been investigated but is not commonly performed.

Transcatheter interventions do play a major role in the rehabilitation of the distal pulmonary arteries in the setting of tetralogy of Fallot with pulmonary atresia.

Surgical Therapy

History of the procedure

Tetralogy of Fallot holds a central place in the history of surgery for congenital heart disease. Tetralogy of Fallot is the first cyanotic cardiac lesion to be successfully managed with surgical palliation and is one of the first cardiac lesions to undergo successful intracardiac repair.

On November 29, 1945, Alfred Blalock performed the first systemic-to-pulmonary artery shunt procedure to palliate tetralogy of Fallot in a child by increasing pulmonary blood flow.1 Blalock used a subclavian artery–to–pulmonary artery anastomosis, which was named the Blalock-Taussig shunt (BT shunt) after the cardiac surgeon who initially performed the operation on human children and a cardiologist, Helen B. Taussig. The anastomosis was developed in the animal research laboratory at Johns Hopkins University by the surgical technician Vivien T. Thomas working with Blalock. This was the first truly successful palliation of congenital heart disease and created an international sensation. "Blue babies" from all over the world came to the Johns Hopkins Hospital in Baltimore to be treated.

In 1946, Potts descried a descending aorta–to–pulmonary artery systemic-to-pulmonary artery shunt (Potts-Smith shunt).2 In 1962, Waterston described an ascending aorta–to–pulmonary artery systemic-to-pulmonary artery shunt.3 The Potts-Smith and Waterston type shunt procedures were technically easier to perform than classic BT shunting in small infants. However, both the Potts-Smith and Waterston shunts often resulted in excessive pulmonary blood flow, distortion of the pulmonary artery, and problems during subsequent complete tetralogy of Fallot repair. As a consequence, these 2 shunts are essentially no longer used.

The classic BT shunt procedure developed in 1945 involved direct end-to-end anastomosis between the subclavian artery and the pulmonary artery. This technique required transection of the subclavian artery. At The Great Ormond Street Hospital for Children in London, England, Professor Marc deLeval modified this procedure using an interposition conduit between subclavian artery and pulmonary artery. Known as the modified BT shunt, this is currently the most commonly used systemic-to–pulmonary artery shunt. Synonyms for the modified BT shunt include the deLeval shunt and the GOS shunt.

Since the introduction of cardiopulmonary bypass, the trend has been for early and complete repair. C. Walt Lillehei performed the first successful intracardiac repairs by using cross-circulation, an innovative technique involving parental bypass in which the patient's circulation is attached to and supported by the parent's circulation.4 In 1954, Lillehei and Varco performed the first intracardiac repair of tetralogy of Fallot by using parental cross-circulation at the University of Minnesota. They closed a ventricular septal defect (VSD) and relieved an RVOT obstruction (RVOTO) under direct vision.

Although this innovative technique was the first surgical procedure with the potential for a 200% mortality rate (patient and parent), it also acted as a stimulus for the subsequent development of a functional mechanical cardiopulmonary bypass machine. In 1955, Kirklin performed the first successful repair of tetralogy of Fallot with a pump oxygenator was performed 90 miles away from the University of Minnesota at the Mayo Clinic.5 Today, the cardiopulmonary bypass machine is used to perform complete intracardiac repair of tetralogy of Fallot, as described below.

Surgical decision making

A systemic-to-pulmonary artery shunt is indicated in patients in whom the risk in complete repair is considered to be higher than the cumulative risk in 2-stage repair.

The timing and type of surgical intervention in tetralogy of Fallot is controversial. In asymptomatic patients, elective repair has been advocated from the neonatal period up until age 1 year. Most surgeons perform repair in infants with asymptomatic tetralogy of Fallot between age 4 and 6 months. In symptomatic or cyanotic patients, depending on institutional preferences, complete repair can be performed as a primary single-stage procedure or as a 2-stage approach, with initial systemic-to–pulmonary artery shunting.

Preoperative Details

The preoperative evaluation includes an assessment of functional status and pulmonary evaluation. Chest radiographic findings may depict the classic boot-shaped heart. Echocardiography is diagnostic, and associated anomalies can be excluded. Cardiac catheterization is indicated before repair of tetralogy of Fallot in patients with previous palliation and when aortopulmonary collaterals and pulmonary artery branching abnormalities are suspected.

Intraoperative Details

Palliative surgery

The role of palliative surgery for tetralogy of Fallot is controversial. Patients whose conditions are refractory to medical management and stabilization require urgent surgical intervention. In some centers, these patients are treated with initial surgical palliation with a systemic-to–pulmonary artery shunt and subsequent complete repair. In other centers, these children are treated with urgent primary complete repair.

Creation of a systemic-to–pulmonary artery shunt can be performed from the midline by means of a sternotomy or thoracotomy. Advantages of the sternotomy approach include the simple use of cardiopulmonary bypass if necessary. Advantages of the thoracotomy approach include the preservation of a virgin sternotomy approach with a simplified sternotomy for the eventual complete repair with minimal adhesions.

A modified BT shunt procedure is most commonly performed by using a polytetrafluoroethylene (Gore-Tex; W.L. Gore & Associates, Newark, DE) tube graft anastomosed end-to-side to the right subclavian artery and end-to-side to the right pulmonary artery. The modified BT shunt is most commonly created on the side opposite the aortic arch. Therefore, with a left aortic arch, a right modified BT shunt is typically created. With a right aortic arch, a left modified BT shunt is typically created.

Corrective surgery

Complete repair can be performed as a single-stage procedure or as a 2-stage approach, with initial systemic-to–pulmonary artery shunting.

Complete surgical repair involves closure of the VSD and relief of the RVOTO. A median sternotomy approach is used with cardiopulmonary bypass.

Two potential surgical approaches are the transventricular approach and the transatrial approach. Transventricular repair with a right ventriculotomy in the infundibulum allows for exposure of the VSD and patch closure of the infundibular incision. With the transatrial approach, the VSD and subpulmonary obstruction can be approached from a transatrial direction. Muscle resection is performed to relieve the RVOTO.

The goals of complete repair are relief of all obstruction to blood flow from the RV to the pulmonary artery and closure of the VSD. The relief of RVOTO may involve resection of obstructing RVOT muscle bundles, creation of an RVOT patch, creation of a transannular RVOT patch, pulmonary valvotomy or valvectomy, and pulmonary arterioplasty of the main and branch pulmonary arteries. The VSD is usually closed with a patch taking great care to avoid damage to the conduction system.

Assessment of the pulmonary annulus using predicted mean-normal diameters of the pulmonary valve annulus corrected for body surface area provides some guidance for enlarging the pulmonary annulus (transannular patching). A conduit connection from the RV to the pulmonary arteries may be necessary in patients with pulmonary atresia, anomalies of the coronary arteries, or severe multilevel obstruction and hypoplasia. Distal pulmonary arteries and branch pulmonary artery stenosis can be managed at the time of surgery by using autologous pericardial patch enlargement. Additional work on the branch pulmonary arteries can be accomplished preoperatively and postoperatively by means of the transcatheter approach.

In neonates and young infants, use of a transannular patch is most likely, and extensive RVOT muscle resection is not usually necessary. In older children, use of a transannular patch is relatively unlikely, and extensive RVOT muscle resection is common.

Postoperative Details

After surgery, various residual abnormalities may be encountered, ranging from a nearly normal-appearing heart to one in which substantial RV dysfunction and residual RVOTO.

Two-dimensional echocardiography and Doppler techniques can be the definitive means for monitoring patients with respect to the recovery of RV function and the development of complications, such as recurrent RVOTO and residual or recurrent VSD.

Postoperative pulmonary insufficiency can be associated with late RV dysfunction and may necessitate intervention.

Follow-up

Clinical, ECG, and echocardiographic follow-up monitoring is indicated. Echocardiography is the diagnostic modality of choice for follow-up.

Complications

Today, the mortality risk for uncomplicated tetralogy of Fallot (TOF) repair should approach 0%.

Complications of the surgery include the following:

  • Hemorrhage
  • Infection
  • Heart block
  • Residual or recurrent ventricular septal defect (VSD)
  • Residual or recurrent right ventricular (RV) outflow tract obstruction (RVOTO)
  • Pulmonary insufficiency
  • RV dysfunction
  • Heart failure

More on Tetralogy of Fallot: Surgical Perspective

Overview: Tetralogy of Fallot: Surgical Perspective
Workup: Tetralogy of Fallot: Surgical Perspective
Treatment: Tetralogy of Fallot: Surgical Perspective
Follow-up: Tetralogy of Fallot: Surgical Perspective
References

References

  1. Blalock A, Taussig HB. Landmark article May 19, 1945: The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. By Alfred Blalock and Helen B. Taussig. JAMA. Apr 27 1984;251(16):2123-38. [Medline].

  2. Potts WJ, Smith S, Gibson S. Anastomosis of the aorta to a pulmonary artery. JAMA. 1946;132:627.

  3. Waterston DJ. [Treatment of Fallot's tetralogy in children under 1 year of age.]. Rozhl Chir. Mar 1962;41:181-3. [Medline].

  4. Lilleheil CW, Cohen M, Warden HE, et al. Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases. Ann Surg. Sep 1955;142(3):418-42. [Medline].

  5. Kirklin JW, Dushane JW, Patrick RT, et al. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (gibbon type): report of eight cases. Mayo Clin Proc. May 18 1955;30(10):201-6. [Medline].

  6. Kirklin JK, Kirklin JW, Blackstone EH, Milano A, Pacifico AD. Effect of transannular patching on outcome after repair of tetralogy of Fallot. Ann Thorac Surg. Dec 1989;48(6):783-91. [Medline].

  7. Jacobs JP, Jacobs ML, Mavroudis C, Lacour-Gayet F. Third Harvest (1998-2002). The Society of Thoracic Surgeons Congenital Heart Surgery Database. Available at www.ctsnet.org/file/WEB_DOCUMENT_2003CongenitalReportOverview.pdf.

  8. Jacobs ML. Congenital Heart Surgery Nomenclature and Database Project: tetralogy of Fallot. Ann Thorac Surg. Apr 2000;69(4 Suppl):S77-82. [Medline].

  9. Walters HL, Mavroudis C, Tchervenkov CI, et al. Congenital Heart Surgery Nomenclature and Database Project: double outlet right ventricle. Ann Thorac Surg. Apr 2000;69(4 Suppl):S249-63. [Medline].

  10. Bergersen LJ, Perry SB, Lock JE. Effect of cutting balloon angioplasty on resistant pulmonary artery stenosis. Am J Cardiol. Jan 15 2003;91(2):185-9. [Medline].

  11. Castaneda AR, Mayer J. Tetralogy of Fallot. In: Stark J, deLeval M, eds. Surgery for Congenital Heart Defects. 2nd ed. Philadelphia, Pa: WB Saunders; 1994:405-16.

  12. Cho JM, Puga FJ, Danielson GK, Dearani JA, Mair DD, Hagler DJ. Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg. Jul 2002;124(1):70-81. [Medline].

  13. Cobanoglu A, Schultz JM. Total correction of tetralogy of Fallot in the first year of life: late results. Ann Thorac Surg. Jul 2002;74(1):133-8. [Medline].

  14. Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JC. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. Dec 4 2002;40(11):2044-52. [Medline].

  15. Fallot A. Anatomie pathologique de la maladie bleue. Marseille-Medial. 1888;25:77-420.

  16. Fellows KE, Freed MD, Keane JF, et al. Results of routine preoperative coronary angiography in tetralogy of Fallot. Circulation. Mar 1975;51(3):561-6. [Medline].

  17. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. Nov 6 2002;40(9):1675-80. [Medline].

  18. Hamada H, Terai M, Jibiki T, Nakamura T, Gatzoulis MA, Niwa K. Influence of early repair of tetralogy of fallot without an outflow patch on late arrhythmias and sudden death: a 27-year follow-up study following a uniform surgical approach. Cardiol Young. Jul 2002;12(4):345-51. [Medline].

  19. Helbing WA, Roest AA, Niezen RA, Vliegen HW, Hazekamp MG, Ottenkamp J. ECG predictors of ventricular arrhythmias and biventricular size and wall mass in tetralogy of Fallot with pulmonary regurgitation. Heart. Nov 2002;88(5):515-9. [Medline].

  20. Hirsch JP, Bove EL. Tetralogy of Fallot. In: Mavroudis C, Backer DL, eds. Pediatric Cardiac Surgery. 3rd ed. Philadelphia, Pa: Mosby Elsevier; 2003:383-97.

  21. Jacobs JP. Nomenclature and classification for congenital cardiac Surgery. In: Mavroudis C, Backer CL, eds. Pediatric Cardiac Surgery. 3rd ed. Philadelphia, PA: Mosby; 2003:25-38.

  22. Jacobs JP, Jacobs ML, Mavroudis C, Lacour-Gayet F. Fourth Harvest - (2002-2003). The Society of Thoracic Surgeons Congenital Heart Surgery Database. Available at www.ctsnet.org/file/2004CongenitalReportOverview.pdf.

  23. Mavroudis C, Jacobs JP. International Congenital Heart Surgery Nomenclature and Database Project. Ann Thorac Surg. Apr 2000;69(Suppl):S1-372.

  24. Monro JL. Editorial comment Late outcomes following repair of tetralogy of Fallot. Eur J Cardiothorac Surg. Nov 4 2008;[Medline].

  25. Moon-Grady AJ, Tacy TA, Brook MM, Hanley FL, Silverman NH. Value of clinical and echocardiographic features in predicting outcome in the fetus, infant, and child with tetralogy of Fallot with absent pulmonary valve complex. Am J Cardiol. Jun 1 2002;89(11):1280-5. [Medline].

  26. Mulder TJ, Pyles LA, Stolfi A, Pickoff AS, Moller JH. A multicenter analysis of the choice of initial surgical procedure in tetralogy of Fallot. Pediatr Cardiol. Nov-Dec 2002;23(6):580-6. [Medline].

  27. Pacifico AD, Kirklin JW, Bargeron LM. Complex congenital malformations. In: Kirklin JW, ed. Advances in Cardiovascular Surgery. London: Grune and Stratton; 1973:57.

  28. Quintessenza JA, Jacobs JP, Chai PJ, et al. Late replacement of the pulmonary valve: when and what type of valve?. Cardiol Young. Feb 2005;15 Suppl 1:58-63. [Medline].

  29. Quintessenza JA, Jacobs JP, Morell VO, et al. Initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann Thorac Surg. Mar 2005;79(3):924-31. [Medline].

  30. Stark J. Double outlet ventricles. In: Stark J, deLeval M, eds. Surgery for Congenital Heart Defects. 2nd ed. Philadelphia, Pa: WB Saunders; 1994:437-46.

  31. Stayer SA, Shetty S, Andropoulos DB. Perioperative management of tetralogy of Fallot with absent pulmonary valve. Paediatr Anaesth. Oct 2002;12(8):705-11. [Medline].

  32. Therrien J, Marx GR, Gatzoulis MA. Late problems in tetralogy of Fallot--recognition, management, and prevention. Cardiol Clin. Aug 2002;20(3):395-404. [Medline].

  33. van Doorn C. The unnatural history of tetralogy of Fallot: surgical repair is not as definitive as previously thought. Heart. Nov 2002;88(5):447-8. [Medline].

  34. Van Praagh R, Van Praagh S, Nebesar RA, et al. Tetralogy of Fallot: underdevelopment of the pulmonary infundibulum and its sequelae. Am J Cardiol. Jul 1970;26(1):25-33. [Medline].

  35. Van Praagh S, Davidoff A, Chin A. Double outlet right ventricle. Coeur. 1981;13:389-440.

  36. Warnes CA, Child JS. Aortic root dilatation after repair of tetralogy of Fallot: pathology from the past?. Circulation. Sep 10 2002;106(11):1310-1. [Medline].

Further Reading

Keywords

tetralogy of Fallot, TOF, Fallot's tetralogy, Fallot's tetrad, ventricular septal defect, VSD, right ventricular outflow tract obstruction, RVOTO, aorta overriding the ventricular septum, right ventricular hypertrophy, RVH, common atrioventricular canal, atrioventricular septal defect, AVSD, complete AVSD, cyanotic heart defect, absent pulmonary valve syndrome, pulmonary atresia, pulmonary stenosis, infundibular stenosis, polycythemia, growth retardation, brain abscess, stroke, aortic regurgitation, atrial septal defect, secundum atrial septal defect, patent foramen ovale, patent ductus arteriosus 

Contributor Information and Disclosures

Author

Vibhuti N Singh, MD, MPH, FACC, FSCAI, Director, Suncoast Cardiovascular Center; Chair, Cardiology Division and Cath Labs, Department of Medicine, Bayfront Medical Center; Clinical Assistant Professor, Division of Cardiology, University of South Florida College of Medicine
Vibhuti N Singh, MD, MPH, FACC, FSCAI is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, and Florida Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Jeffrey P Jacobs, MD, FACS, FACC, FCCP, Clinical Associate Professor, Department of Surgery, University of South Florida College of Medicine; Medical Director, ECMO Program, Division of Thoracic and Cardiovascular Surgery, All Children's Hospital/Bayfront Medical Center
Jeffrey P Jacobs, MD, FACS, FACC, FCCP is a member of the following medical societies: American Association for Thoracic Surgery, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, Congenital Heart Surgeons Society, Society of Thoracic Surgeons, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

Medical Editor

Jeff L Myers, MD, PhD, Chief, Pediatric and Congenital Cardiac Surgery, Department of Surgery, Massachusetts General Hospital; Associate Professor of Surgery, Harvard Medical School
Jeff L Myers, MD, PhD is a member of the following medical societies: American College of Surgeons, American Heart Association, and International Society for Heart and Lung Transplantation
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation

Managing Editor

Robert DB Jaquiss, MD, Professor of Surgery, University of Arkansas for Medical Sciences; Chief, Pediatric Cardiothoracic Surgery, Arkansas Children's Hospital and Chief, Cardiothoracic Surgery, University of Arkansas for Medical Sciences
Robert DB Jaquiss, MD is a member of the following medical societies: American Academy of Pediatrics, American Association for Thoracic Surgery, American College of Cardiology, American College of Surgeons, American Heart Association, Congenital Heart Surgeons Society, International Society for Heart and Lung Transplantation, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting; Pfizer Honoraria Consulting

Chief Editor

John Kupferschmid, MD, Director of Congenital Heart Surgery, Department of Surgery, Methodist Children's Hospital at San Antonio
John Kupferschmid, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, Society of Thoracic Surgeons, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.